Dr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor in both the Departments of Medicine and Engineering at Stanford. Presently, Dr. Fitzgerald’s laboratory includes 14 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. He has led or participated in over 100 clinical trials, published over 350 manuscripts/chapters, and lectures worldwide. He has trained over 125 post-docs in Engineering and Medicine in the past decade.
Peter has been principle/founder of fifteen medical device companies in the San Francisco Bay Area. He has transitioned ten of these start-ups to large medical device companies. He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Peter was part of the founding team of LVP Capital, a venture firm, focused on medical device and biotechnology start-ups in San Francisco. In 2008, was co-founded of TriVentures, which is an incubator for early state medical technology in Israel and heads the Stanford-Taiwan Med Tech innovation program.